BCRX
BioCryst Pharmaceuticals Inc
8.60$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 263.0% | -60.0% | -7.8% | -20.0% | 376.4% | 135.3% | 962.7% | 177.4% | 2,947.8% | 8,978.3% | 529.0% | 101.0% | 82.8% | 6.1% | 0.1% | 347.1% | 0.5% | 0.6% | 0.9% | 3.9% | 10.2% | 6.8% | 2.3% | 8.4% | 9.4% | 4.6% | 2.4% | 1.4% | 2.8% | 2.2% | |
| -163.0% | 160.0% | 107.8% | 120.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.9% | 99.9% | 100.0% | 99.5% | 99.4% | 99.1% | 96.1% | 89.8% | 93.2% | 97.7% | 91.6% | 90.6% | 95.4% | 97.6% | 98.6% | 97.2% | 97.8% | |
| – | 1,060.0% | 145.3% | 308.0% | 289.2% | 117.3% | 872.0% | 705.1% | 5,600.5% | 15,567.8% | 758.0% | 132.0% | 129.6% | 96.9% | 129.9% | 289.7% | 195.7% | 246.6% | 380.6% | 150.8% | 231.5% | 265.9% | 411.0% | 219.2% | 690.3% | 132.9% | 93.5% | 65.3% | 38.7% | 19.0% | |
| 100.0% | 270.0% | 48.4% | 116.0% | 107.3% | 27.4% | 160.9% | 172.1% | 953.5% | 2,427.3% | 98.3% | 13.3% | 18.4% | 15.4% | 22.3% | 62.8% | 26.0% | 30.1% | 54.8% | 27.0% | 42.7% | 55.3% | 142.9% | 76.0% | 344.5% | 72.0% | 53.3% | 60.1% | 56.0% | 39.9% | |
| 118.5% | 1,390.0% | 201.6% | 444.0% | 396.5% | 144.7% | 1,032.9% | 877.2% | 6,556.5% | 17,995.2% | 856.3% | 145.3% | 148.0% | 112.3% | 152.2% | 352.4% | 221.7% | 276.7% | 435.5% | 177.8% | 274.2% | 321.2% | 553.9% | 295.3% | 1,071.7% | 208.5% | 152.4% | 129.9% | 97.8% | 58.8% | |
| -281.5% | -1,230.0% | -93.8% | -324.0% | -296.5% | -44.7% | -932.9% | -777.2% | -6,456.5% | -17,895.2% | -756.3% | -45.3% | -48.0% | -18.4% | -52.3% | -252.4% | -128.9% | -177.2% | -336.4% | -81.7% | -184.4% | -227.9% | -456.2% | -203.7% | -981.1% | -113.1% | -54.8% | -31.3% | -0.6% | 39.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 19.2% | 17.7% | 27.6% | 36.7% | 10.8% | 24.6% | 34.0% | 44.4% | 24.4% | 81.4% | 37.7% | 36.6% | 32.7% | 21.9% | 9.0% | |
| -311.1% | -1,060.0% | -73.4% | -276.0% | -349,193.6% | -44,686.7% | -953,983.8% | -777,238.9% | -6,264,190.7% | -17,185,279.2% | -420,139.0% | -40.8% | -43.7% | -18.0% | -53,311.3% | -289.9% | -148.6% | -173.7% | -332.1% | -89.1% | -209.3% | -261.2% | -490.3% | -223.0% | -1,026.4% | -115.7% | -90.2% | -68.3% | -19.3% | 30.6% | |
| 3.7% | -170.0% | -18.8% | -112.0% | -348,844.4% | -44,642.0% | 21.1% | -776,461.6% | -192.3% | 709,164.6% | -419,436.9% | 0.0% | 0.0% | -2.2% | 788.6% | 33.0% | 15.4% | 25.8% | 35.4% | 10.4% | 22.8% | 31.2% | 10.4% | 22.9% | 77.2% | 1.4% | 1.0% | 0.1% | 0.4% | 0.4% | |
| -285.2% | -1,060.0% | -75.0% | -212.0% | -349.2% | -44.7% | -954.0% | -777.2% | -6,264.2% | -17,185.3% | -702.2% | -40.8% | -43.7% | -18.0% | -51.5% | -289.9% | -148.6% | -173.7% | -332.1% | -89.1% | -209.3% | -261.2% | -490.3% | -223.0% | -1,026.4% | -117.1% | -91.2% | -68.4% | -19.7% | 30.2% | |
| -303.7% | -1,170.0% | -85.9% | -304.0% | -276.4% | -35.3% | -983.7% | -769.8% | -5,976.4% | -16,616.0% | -688.9% | -38.9% | -40.9% | -16.3% | -48.8% | -266.2% | -128.5% | -144.4% | -294.0% | -78.0% | -182.8% | -224.4% | -437.5% | -197.2% | -940.7% | -77.5% | -53.1% | -35.1% | 2.8% | 39.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.